Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation.
Costa F, Toscani D, Chillemi A, Quarona V, Bolzoni M, Marchica V, Vescovini R, Mancini C, Martella E, Campanini N, Schifano C, Bonomini S, Accardi F, Horenstein AL, Aversa F, Malavasi F, Giuliani N. Costa F, et al. Among authors: campanini n. Oncotarget. 2017 May 16;8(34):56598-56611. doi: 10.18632/oncotarget.17896. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915615 Free PMC article.
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.
Storti P, Toscani D, Airoldi I, Marchica V, Maiga S, Bolzoni M, Fiorini E, Campanini N, Martella E, Mancini C, Guasco D, Ferri V, Donofrio G, Aversa F, Amiot M, Giuliani N. Storti P, et al. Among authors: campanini n. Haematologica. 2016 Mar;101(3):e107-10. doi: 10.3324/haematol.2015.133736. Epub 2015 Dec 11. Haematologica. 2016. PMID: 26659917 Free PMC article. No abstract available.
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.
Storti P, Marchica V, Airoldi I, Donofrio G, Fiorini E, Ferri V, Guasco D, Todoerti K, Silbermann R, Anderson JL, Zhao W, Agnelli L, Bolzoni M, Martella E, Mancini C, Campanini N, Noonan DM, Petronini PG, Neri A, Aversa F, Roodman GD, Giuliani N. Storti P, et al. Among authors: campanini n. Leukemia. 2016 Dec;30(12):2351-2363. doi: 10.1038/leu.2016.137. Epub 2016 May 20. Leukemia. 2016. PMID: 27311934
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy.
Marchica V, Franceschi V, Vescovini R, Storti P, Vicario E, Toscani D, Zorzoli A, Airoldi I, Dalla Palma B, Campanini N, Martella E, Mancini C, Costa F, Donofrio G, Giuliani N. Marchica V, et al. Among authors: campanini n. J Hematol Oncol. 2020 Jul 11;13(1):89. doi: 10.1186/s13045-020-00919-w. J Hematol Oncol. 2020. PMID: 32653014 Free PMC article.
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability.
Chiu M, Toscani D, Marchica V, Taurino G, Costa F, Bianchi MG, Andreoli R, Franceschi V, Storti P, Burroughs-Garcia J, Eufemiese RA, Dalla Palma B, Campanini N, Martella E, Mancini C, Shan J, Kilberg MS, D'Amico G, Dander E, Agnelli L, Pruneri G, Donofrio G, Bussolati O, Giuliani N. Chiu M, et al. Among authors: campanini n. Cancers (Basel). 2020 Nov 5;12(11):3267. doi: 10.3390/cancers12113267. Cancers (Basel). 2020. PMID: 33167336 Free PMC article.
Is CD10 a reliable marker of invasive colorectal cancer?
Del Rio P, Crafa P, Papadia C, Benecchi L, Campanini N, Sianesi N, Montana CM, Sianesi M. Del Rio P, et al. Among authors: campanini n. Ann Ital Chir. 2011 Jul-Aug;82(4):279-82. Ann Ital Chir. 2011. PMID: 21834477
CD133 is a selective marker of CRC?
Del Rio P, Bonati E, Crafa P, Campanini N, Montana Montana C, Bezer L, Dell'Abate P, Sianesi M. Del Rio P, et al. Among authors: campanini n. Minerva Chir. 2013 Feb;68(1):87-95. Minerva Chir. 2013. PMID: 23584268
71 results